Neutralization of pro-inflammatory cytokines such as IL-6, TNF-α, VEGF, and IFN-α/β, as well as anti-inflammatory IL-4, during severe pulmonary disease may help reduce ongoing parenchymal damage in the MTB-infected lung [27,45–47]. The gene discussed is IL4; the disease is lung disorder.